Abstract:
Two electronics giants -- Intel Corp. and the makers of Panasonic-brand products -- are diving into one of the most promising new fields of medical science: nanobiotechnology, according to NanoBiotech News. From molecular detectors in toothbrushes to monitor potassium levels in heart failure patients to tiny generators that would use electricity produced from human blood glucose to run devices embedded in a patient's body, these corporate behemoths are exploring an emerging market that is expected to exceed $1 trillion within a decade.